The role of IGFBP7, mimecan and osteopontin in the management of heart failure with preserved and reduced ejection fraction.
29 April 2017 (00:00 - 00:00)
Organised by:
About the speaker
Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
76 More presentations in this session
Professor Z. Rasulova (Tashkent, UZ)
Doctor A. Khan (Hannover, DE)
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April - 2 May 2017
